Table
of Contents
|
|
|
|
Introduction |
vii |
Preface |
Carole Mensing
Rn, Ma, Cde, Faade |
ix |
|
Acknowledgements |
xiii |
Section 1 |
The Art of Diabetes
Self-Management Education Section |
|
|
Overview Sue Mclaughlin,
BS, RD, CDE, CPT |
1 |
Chapter 1 |
Diabetes
Self-Management Education: the Art and Science of Disease Management Sandra Drozdz Burke, PhD ANP BC-ADM, CDE,
FAADE and Ann Vannice,
MSN, APRN, CDE |
3 |
Chapter 2 |
The
Diabetes Self-Management Education Process Kim Decoste, Rn, MSN, CDE and Lois Maurer, MS,
RD, LDN, CDE |
21 |
Chapter 3 |
Theoretical
and Behavioral Approaches to The Self-Management
of Health Boh Anderson, EdD and Martha M. Funnell, MS, RN, CDE |
71 |
Chapter 4 |
Healthy
Eating Patti B.
Geil, MS, RD,
FADA, CDE |
95 |
Chapter 5 |
Being
Active Sheri R.
Colberg, PhD,
FACSM |
117 |
Chapter 6 |
Taking
Medications Devra K.
Dang, PharmD,
BCPS, CDE |
147 |
Chapter 7 |
Monitoring Mary M. Austin, MA, RD,
CDE, FAADE and Margaret A. Powers,
PhD, RD, CDE |
167 |
Chapter 8 |
Problem
Solving Joseph B.
Nelson MA, LP, CST and Katherine I.
Nelson WaRD,
MPH, CHES |
195 |
Chapter 9 |
Healthy
Coping Joseph B.
Nelson MA, LP CST and Katherine I.
Nelson Ward, MPH, CHES |
217 |
Chapter 10 |
Reducing
Risks Ann L Albright, PhD, RD |
239 |
Chapter 11 |
Diabetes
Education Program Management Melinda Maryniuk, MEd, RD, CDE, FADA and Linda Siminerio, RN,
PhD, CDE |
259 |
Section 2 |
The Science of Diabetes
Self-Management Education |
|
|
Section
Overview Cindy Halstemon, RD, LD, CDE |
281 |
Chapter 12 |
Pathophysiology of the Metabolic DisoRDer Joan K.
BaRDsley, RN,
MBA, CDE, FAADE and Michelle F Magee, MD, MBBch, BAO, LRCPSI |
285 |
Chapter 13 |
Type 1
Diabetes Throughout the Life Span Carolyn Bunion, RN, MN, CPNP, CDE and
Virginia Valentine, CNS, BC-ADM, CDE, FAADE |
309 |
Chapter 14 |
Type 2
Diabetes Across the Life Span Geralyn R.
Spollett, MSN,
ANP, CDE |
341 |
Chapter 15 |
Medical
Nutrition Therapy Marion J.
Franz, MS, RD, LD, CDE and Margaret A.
Powers, PhD, RD, LN, CDE |
361 |
Chapter 16 |
Exercise
Prescription Sheri R.
Colberg, PhD,
FACSM |
385 |
Chapter 17 |
Pharmacotherapy
for Glucose Management Evan M.
Sisson, PhannD,
MSHA, CDE and Susan Cornell, BS, PharmD, CDE, FAPha, FAADE |
417 |
Chapter 18 |
Pharmacotherapy:
Dyslipidemia
and Hypertension in Persons with Diabetes Susan Cornell, BS, Pharm
D, CDE, FAPha,
FAADE and Evan M. Sisson, PharmD, MSHA, CDE |
459 |
Chapter 19 |
Biologically-Based
Practices: a Focus on Dietary Supplements for
Diabetes Laura Shane-McWhorter, PharmD, BCPS, FASCP, BC-ADM, CDE,
FAADE |
495 |
Chapter 20 |
Combating
Clinical Inertia through Pattern Management
and Intensifying Therapy Debbie Hinnen ARNP, BC-ADM, CDE, FAAN,
FAADE and Donna Tomky
MSN, APRN, C-ANP, CDE, FAADE |
531 |
Chapter 21 |
Hyperglycemia Dace L. Trence, MD, FACE |
577 |
Chapter 22 |
Chronic
Complications Samuel L.
Abbate, MD, CDE
and Anne J. Abbate, RN, CDE |
603 |
Chapter 23 |
Pregnancy
with Diabetes Diane M.
Reader, RD, CDE and Alyce
Thomas, RD |
621 |
Chapter 24 |
Macrovascular Disease in
Diabetes Daniel Lorber, MD, FACP, CDE |
659 |
Chapter 25 |
Eye Disease
Related to Diabetes SzildRD Kiss, MD |
699 |
Chapter 26 |
Diabetic
Kidney Disease Laura D.
Byham-Gray, PhD,
RD |
717 |
Chapter 27 |
Diabetic
Neuropathies Aaron I.
Vinikv Md, PhD FCP,
MACP and Etta ]. Vinik, MA (Ed) |
737 |
|
Index |
767 |
|
|
|